Article
Alternative lengthening of telomeres (ALT) in pediatric high-grade gliomas can occur without ATRX mutation and is enriched in patients with pathogenic germline mismatch repair (MMR) variants.
Neuro-oncology - 6 Jul 2023
Stundon Jennifer L, Ijaz Heba, Gaonkar Krutika S, Kaufman Rebecca S, Jin Run, Karras Anastasios, Vaksman Zalman, Kim Jung, Corbett Ryan J, Lueder Matthew R, Miller Daniel P, Guo Yiran, Santi Mariarita, Li Marilyn, Lopez Gonzalo, Storm Phillip B, Resnick Adam C, Waanders Angela J, MacFarland Suzanne P, Stewart Douglas R, Diskin Sharon J, Rokita Jo Lynne, Cole Kristina A
Abstract excerpt
BACKGROUND: To achieve replicative immortality, most cancers develop a telomere maintenance mechanism, such as reactivation of telomerase or alternative lengthening of telomeres (ALT). There are limited data on the prevalence and clinical significance of ALT in pediatric brain tumors, and ALT-directed therapy is not available. METHODS: We performed C-circle analysis (CCA) on 579 pediatric brain tumors that had...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
